Navigation path

Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Suvaxyn Aujeszky 783 + O/W   
Auth. number : EU/2/98/009
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AD - Live viral vaccines
Chemical substance: QI09AD01 - Aujeszky´s disease virus
(See WHO ATCvet Index)
Indication: Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus. Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky’s disease and to reduce the excretion of Aujeszky’s disease field virus.
- Active immunity: The onset of immunity is from 3 weeks after basic vaccination. The immunity lasts for 3 months after basic vaccination.
Marketing Authorisation Holder: Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/08/1998 Centralised - Authorisation EMEA/V/C/38 (1998)2460 of 07/08/1998
23/03/2000 Centralised - Variation EMEA/V/C/38/I/1 (2000)720 of 16/03/2000
08/04/2002 Centralised - Variation (no change in Commission Decision) EMEA/V/C/38/II/2
22/05/2002 Centralised - Variation EMEA/V/C/38/II/3 (2002)1964 of 17/05/2002
18/02/2003 Centralised - Variation EMEA/V/C/38/II/4 (2003)601 of 14/02/2003
17/03/2004 Centralised - Renewal EMEA/V/C/38/R/6 (2004)885 of 15/03/2004
23/02/2006 Centralised - Variation (no change in Commission Decision) EMEA/V/C/38/IB/8
26/08/2008 Centralised - Renewal EMEA/V/C/38/R/9 (2008)4660 of 22/08/2008
17/10/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/38/II/11
17/10/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/38/II/10
30/08/2011 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/38/T/12 (2011)6185 of 24/08/2011
11/10/2011 Centralised - Variation EMEA/V/C/38/IA/13/G
Updated with Decision(2012)639 of 31/01/2012
09/11/2011 Centralised - Variation EMEA/V/C/38/IA/14/G
Updated with Decision(2012)639 of 31/01/2012
03/02/2012 Centralised - Variation (2012)639 of 31/01/2012
03/09/2012 Centralised - Variation EMEA/V/C/38/II/15/G (2012)6133 of 30/08/2012
11/07/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/38/T/16 (2013)4446 of 09/07/2013
05/09/2013 Centralised - Variation EMEA/V/C/38/IAin/17/G
Updated with Decision(2014)6262 of 01/09/2014
03/09/2014 Centralised - Yearly update (2014)6262 of 01/09/2014